UK AI Safety Bill Delayed Amid US Influence

The UK's AI Safety Bill faces delays amid political maneuvers to align with US policies.

The United Kingdom’s highly anticipated AI Safety Bill has hit a roadblock, raising concerns about the government’s commitment to regulating artificial intelligence technologies. According to Chi Onwurah, the head of the Science, Innovation, and Technology Select Committee, the delay in pushing the legislation forward appears politically motivated. It is suspected that the delay aims to align more closely with the US, particularly the Trump administration’s stance against extensive AI regulation.

The bill initially aimed to legally compel companies to submit their frontier AI models for government safety evaluations, a promise made by firms like OpenAI and Google DeepMind during international talks. Despite technology secretary Peter Kyle’s assurance in November 2024 to implement the legislation, the expected release has been postponed, sparking concerns about the possible influence of international politics over national safety priorities.

This strategic shift towards innovation and economic growth raises questions. Some speculate that this might be a move to appease the US, which has criticized Europe’s regulatory approach as overly restrictive. The delay is reportedly part of broader efforts by the UK to strengthen ties with the US, which may carry significant economic implications. A Microsoft report forecasts that delays in AI integration could cost the UK economy over £150 billion in the coming years.

75

Impact Score

Governance gaps emerge as agentic Artificial Intelligence scales

Agentic Artificial Intelligence is moving from assisted chatbots to autonomous workflows faster than enterprise governance is adapting. The shift raises accountability, security, lifecycle, and cost control challenges that organizations must address in operational code from the start.

Where OpenAI technology could appear in Iran

OpenAI’s Pentagon deal and defense partnerships could place its models in targeting workflows, drone defense systems, and military administration tied to the Iran conflict. The company’s role reflects a broader push to weave generative Artificial Intelligence into US military operations.

Artificial Intelligence tumour testing aims to personalize cancer treatment

A UK-funded cancer testing platform is using living tumour replicas and Artificial Intelligence analysis to identify which drugs are most likely to work before treatment starts. Researchers say the approach could reduce ineffective chemotherapy and improve decisions for patients with aggressive cancers.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.